“In the third quarter we experienced a reduction in large capital equipment orders over $300,000, primarily in our domestic neurology business. Although some orders we expected were placed during the quarter at significantly reduced order size, other orders were not placed at all. We believe that the orders we were working on during the third quarter have not been lost, but have been merely delayed, and we expect that they will eventually be placed with Natus,” added Hawkins. “We experienced similar sales activity in late 2008 and early 2009 and then saw those delayed orders placed in following quarters.”“We look forward to capitalizing on the opportunity that recently acquired Embla Systems brings to our neurology business as we are now a leader in the growing worldwide market for diagnostic sleep products,” added Hawkins. “We expect the Embla acquisition to be accretive to our earnings in 2012, adding approximately $0.08 to non-GAAP earnings per share.”
Natus Medical Announces 2011 Third Quarter Financial Results
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
Every recommendation goes through 3 layers of intense scrutinyquantitative, fundamental and technical analysisto maximize profit potential and minimize risk.
Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.